CLINICAL_TRIALS
trial_result
· 2012-08-07
Clinical Trial Update: GORE® Embolic Filter in Carotid Stenting for High Risk Surgical Subjects (EMBOLDEN) [Phase 3]
Summary
Phase 3 EMBOLDEN trial evaluating the GORE Embolic Filter during carotid artery stenting in high-risk surgical patients; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: W.L.Gore & Associates | Conditions: Carotid Artery Stenosis | Phase 3 | Status: COMPLETED | Results posted: 2012-08-07